Successful use of long-acting octreotide for protracted gastrointestinal bleeding related to protein-losing enteropathy after the Fontan procedure: a case report

Kentaro Kogawa; Tatsuya Ando; Masako Fujiwara

doi:10.1017/S1047951121000391

Successful use of long-acting octreotide for protracted gastrointestinal bleeding related to protein-losing enteropathy after the Fontan procedure: a case report

Cardiol Young. 2021 Aug;31(8):1333-1335. doi: 10.1017/S1047951121000391. Epub 2021 Feb 16.

Authors

Kentaro Kogawa¹, Tatsuya Ando¹, Masako Fujiwara^{1

2}

Affiliations

¹ Department of Paediatrics, The Jikei University School of Medicine, Tokyo, Japan.
² Department of Paediatrics, Machida Municipal Hospital, Tokyo, Japan.

PMID: 33588957
DOI: 10.1017/S1047951121000391

Abstract

Gastrointestinal bleeding complicated with protein-losing enteropathy after the Fontan procedure has been often reported in recent years, but there is no established therapy for it.We report the case of an 18-year-old boy who suffered from abdominal pain, melena, and anaemia due to intractable haemorrhagic protein-losing enteropathy after the Fontan procedure. He was successfully treated with octreotide therapy.

Keywords: The Fontan procedure; gastrointestinal bleeding; intramuscular injection; octreotide; protein-losing enteropathy.

Publication types

Case Reports

MeSH terms

Adolescent
Fontan Procedure* / adverse effects
Gastrointestinal Hemorrhage / drug therapy
Gastrointestinal Hemorrhage / etiology
Humans
Male
Octreotide / therapeutic use
Postoperative Complications
Protein-Losing Enteropathies* / diagnosis
Protein-Losing Enteropathies* / drug therapy
Protein-Losing Enteropathies* / etiology

Substances

Octreotide